HKEX Stock Code: 01093English|繁體|简体
Home > Investor Relations > Announcements & Notices
Announcements & Notices
Dec
31
TERMS OF REFERENCE OF THE AUDIT COMMITTEE
Dec
09
POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON 9 DECEMBER 2015
Nov
30
UNAUDITED RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2015
Nov
19
NOTICE OF EXTRAORDINARY GENERAL MEETING
Nov
18
DATE OF BOARD MEETING
Nov
16
FURTHER DELAY IN DESPATCH OF CIRCULAR
Nov
12
DELAY IN DESPATCH OF CIRCULAR
Nov
02
FORMATION OF INDEPENDENT BOARD COMMITTEE AND APPOINTMENT OF INDEPENDENT FINANCIAL ADVISER
Nov
01
CONTINUING CONNECTED TRANSACTION-MASTER SALES AGREEMENT
Oct
26
(1) APPLICATION FOR WHITEWASH WAIVER;(2) PROPOSED ADOPTION OF THE NEW SHARE OPTION SCHEME;AND(3) RE-ELECTION OF RETIRING DIRECTOR
Sep
07
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Sep
07
CHANGES OF EXECUTIVE DIRECTOR
Aug
25
CHANGE OF COMPANY WEBSITE
Aug
25
2015 INTERIM RESULTS ANNOUNCEMENT
Aug
13
Date of Board Meeting
Aug
05
VOLUNTARY ANNOUNCEMENT - THE GROUP'S COUGH SUPPRESSANT PRODUCT "BENZONATATE SOFT CAPSULE" WAS GRANTED DRUG REGISTRATION APPROVAL BY THE U.S. FDA
May
26
List of Directors and their Role and Function
May
26
RETIREMENT OF EXECUTIVE DIRECTOR AND COMPLIANCE WITH RULE 3.10A OF THE LISTING RULES
May
26
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 26 MAY 2015
May
26
UNAUDITED RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2015
May
13
DATE OF BOARD MEETING
Apr
17
NOTICE OF ANNUAL GENERAL MEETING
Apr
17
SALE OF EXISTING SHARES BY A SUBSTANTIAL SHAREHOLDER
Apr
13
PROPOSED ADOPTION OF NEW ARTICLES OF ASSOCIATION
Mar
24
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2014
Mar
12
Date of Board Meeting
Feb
27
NON-COMPLIANCE WITH RULE 3.10A OF THE LISTING RULES
Jan
19
VOLUNTARY ANNOUNCEMENT - THE GROUP'S ONCOLOGY DRUG WAS GRANTED PHASE II/III CLINICAL TRIAL APPROVAL

Please download the latest "Acrobat Reader" to view the PDF.

© Copyright 2025 CSPC Pharmaceutical Group Limited. All Rights Reserved.
Disclaimer